Position in UTHR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$91,379,087
+$29,360,495 QoQ
Shares Held
168,649
+61.3% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#53
of 870 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $359,418,700 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,525,432 | $109,617,543 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
168,649 | $91,379,087 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
653,736 | $72,525,471 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,470,258 | $36,183,049 | |
| 5 | VTRS |
Viatris Inc
|
997,741 | $15,844,127 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
367,355 | $12,445,987 | |
| 7 | ALKS |
Alkermes plc.
|
118,432 | $6,205,836 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
34,973 | $5,894,349 |
All Filings in UTHR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,379,087 | 168,649 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $62,018,592 | 104,588 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $55,125,028 | 113,135 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $58,211,081 | 138,859 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $38,010,083 | 132,278 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $45,596,523 | 147,911 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $53,086,188 | 150,454 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $51,016,855 | 142,366 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $36,245,255 | 113,782 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $18,730,679 | 81,537 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,240,095 | 82,951 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,606,387 | 7,112 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $742,161 | 3,362 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $741,979 | 3,313 | Shares | Sole | 2023-05-10 | |
| 2022-09-30 | $11,015,691 | 52,611 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $13,487,797 | 57,239 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $7,309,342 | 40,741 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,802,883 | 40,739 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $3,284,680 | 19,637 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,624,153 | 10,700 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $1,118,994 | 11,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||